Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RDM1 pseudogene 2 (RDM1P2) is a human pseudogene related to the RAD52 motif containing 1 (RDM1) gene. Pseudogenes are DNA sequences similar to functional genes; however, they typically do not encode active proteins. While some pseudogenes may influence gene regulation by acting as decoys or competing for microRNAs or RNA-binding proteins, these functions are not universal and have not been documented for RDM1P2 specifically. There is currently no evidence to suggest that RDM1P2 has a role as a drug target, nor is it linked to specific molecular functions or disease processes in the literature. As a pseudogene, RDM1P2 is not considered a canonical therapeutic target, and there are no known drugs, mechanisms of action, or biomarker applications associated with this sequence[1][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RDM1 pseudogene 2 (RDM1P2).